Immunotherapy

Dick Vitale, an ESPN college basketball announcer, reports positive blood test results and effective immunotherapy treatment following his fifth cancer diagnosis. He has previously battled melanoma, lymphoma, vocal cord cancer, and lymph node cancer since 2021. Vitale is associated with the Jimmy V Award and The V Foundation for Cancer Research.

ImmunityBio, Inc. reported a second-quarter loss of $230.4 million, or 22 cents per share, with adjusted losses of 8 cents per share. The company generated $51.2 million in revenue during the period.

William Shatner and his daughter Melanie Shatner Gretsch both battled stage 4 cancer simultaneously, undergoing treatments including chemotherapy, surgery, and immunotherapy. They were declared cancer-free by late 2024 and are launching a podcast to discuss cancer survival. Shatner, 95, had malignant melanoma that spread to his lungs and brain, while Melanie, 61, fought metastatic breast cancer.

William Shatner and his daughter Melanie Shatner Gretsch both survived stage 4 cancer diagnoses. They are now cancer-free and have launched a podcast called 'No Time but Now' to discuss health and survival experiences.

Jeana Keough, an alum of 'RHOC,' is undergoing her fifth week of chemotherapy, radiation, and immunotherapy for tongue cancer. Her children provided an update highlighting her 'strong' condition.

Jeana Keough, a former cast member of 'RHOC,' is undergoing chemotherapy, radiation, and immunotherapy for tongue cancer. Her children shared an update highlighting her strength during treatment.

Scientists discovered that creatine may enhance the immune system's cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The findings suggest potential for improving immunotherapy but have not yet been tested in human patients.

The article discusses the emergence and ongoing promise of immunotherapy for resectable esophageal cancer, a disease historically associated with poor prognosis. It highlights that immunotherapy has provided hope to patients and clinicians, with recent developments suggesting sustained or improved outcomes.

Richard Scolyer, a cancer researcher and former Australian of the year, died at 59. He was diagnosed with inoperable brain cancer in 2023 and conducted pioneering work on immunotherapy. His family shared a statement he wrote before his death.

Mary Suppe, a South Florida teacher, shares her cancer survival story ahead of Cancer Survivors Day, detailing her battle with melanoma that spread to her brain and her recovery through treatment and a positive mindset. She participated in an early immunotherapy clinical trial and now shows no signs of cancer.

A lower-cost immunotherapy approach using ultra-low doses may extend survival for patients with advanced head and neck squamous cell carcinoma in resource-limited countries, according to research presented at the American Society of Clinical Oncology annual meeting.

A triple-action cancer jab has shown 'unprecedentedly strong responses' in eradicating entire tumours in patients whose disease was resistant to chemotherapy and immunotherapy. The international trial involved patients across 11 countries with advanced or recurrent cancer.

The NHS is offering a new injectable form of an immunotherapy drug that can save patients hours in hospital, taking only minutes to administer. Thousands of patients will be eligible for the treatment. The new form of the drug aims to improve patient experience and reduce hospital stay times.

A world-first clinical trial using long-lived T cells that mimic stem cells achieved remission in some blood cancer patients. The study, published in Nature on April 30, 2026, highlights a promising new approach to cancer immunotherapy.

Zeaxanthin, a common nutrient found in vegetables and supplements, may enhance cancer treatment by strengthening T cells and boosting immunotherapy. Scientists suggest it's safe and accessible, with human trials planned as the next step.